---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-086129"
form_type: "8-K"
ticker: "GLUE"
cik: "0001826457"
company_name: "Monte Rosa Therapeutics, Inc."
filed_at: "2025-06-13T23:59:59+00:00"
generated_at: "2026-05-19T08:58:02.181875+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Monte Rosa Therapeutics elects three Class I directors, ratifies auditor at 2025 annual meeting

## Summary
- Elected Christine Siu, Kimberly Blackwell, and Jan Skvarka as Class I directors for three-year terms ending in 2028.
- Christine Siu received 52.1M for, 3.4M withheld; Jan Skvarka received 44.8M for, 10.7M withheld.
- Ratified Deloitte & Touche LLP as independent auditor for FY 2025 with 57.9M for, 139k against, 12.9k abstain.
- Record date April 16, 2025; 61,509,821 shares outstanding.

## SEC filing metadata
- accession: 0000950170-25-086129
- form_type: 8-K
- ticker: GLUE
- cik: 0001826457
- company_name: Monte Rosa Therapeutics, Inc.
- filed_at: 2025-06-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1826457/000095017025086129/0000950170-25-086129-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1826457/000095017025086129/glue-20250613.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-086129
- JSON: https://secwatch.observer/filing/0000950170-25-086129.json
- Plain text: https://secwatch.observer/filing/0000950170-25-086129.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.